Search This Blog

Friday, July 12, 2019

J&J to launch study of HIV vaccine this year

CNBC reports that Johnson & Johnson (JNJ -1.2%) plans to initiate a clinical in the U.S. and Europe evaluating an experimental HIV vaccine.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)